SOAT2 Antibodies

Santa Cruz Biotechnology offers a broad range of SOAT2 monoclonal antibodies for advanced research in lipid metabolism and cellular signaling. SOAT2 Antibodies targeting SOAT2 are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SOAT2, or sterol O-acyltransferase 2, plays a crucial role in cholesterol homeostasis by catalyzing the esterification of free cholesterol, thereby influencing lipid droplet formation and cellular lipid storage. SOAT2 has emerged as a significant factor in metabolic disorders and cardiovascular diseases, making research in this area particularly relevant for therapeutic development. Understanding SOAT2's biological functions and regulatory mechanisms can provide valuable insights into potential treatment strategies for lipid-related disorders. Researchers can utilize SOAT2 monoclonal antibodies to investigate cellular localization patterns and protein-protein interactions. Advanced research techniques supported by SOAT2 monoclonal antibodies enable detailed examination of lipid metabolism pathways and their regulation. Santa Cruz Biotechnology monoclonal antibodies targeting SOAT2 contribute to advancing scientific understanding of lipid metabolism and its role in human health and disease.